Stock listing
NASDAQ:CGIX Cancer Genetics Inc Stock
Follow Cancer Genetics Inc into a list and get an email when it puts out news.
Delisted NASDAQ:CGIX no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:CGIX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Cancer Genetics Inc on 6ix
- Decks
- 25 decks · latest May 16, 2022
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Vyant Bio — Q1 2022 Earnings Presentation | Earnings | 14 slides | May 16, 2022 |
| Merger or Acquisition (January 2021) | Merger or acquisition | 15 slides | Jan 8, 2021 |
| Merger or Acquisition (September 2020) | Merger or acquisition | 22 slides | Sep 15, 2020 |
| Q2 2018 Earnings Presentation | Earnings | 10 slides | Aug 14, 2018 |
| Q1 2018 Earnings Presentation | Earnings | 11 slides | May 15, 2018 |
| FY2017 Earnings Presentation | Earnings | 12 slides | Apr 2, 2018 |
| Q3 2017 Earnings Presentation | Earnings | 13 slides | Nov 9, 2017 |
| Q2 2017 Earnings Presentation | Earnings | 22 slides | Aug 14, 2017 |
| Q1 2017 Earnings Presentation | Earnings | 16 slides | May 12, 2017 |
| FY2016 Earnings Presentation | Earnings | 17 slides | Mar 23, 2017 |
All 25 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2016 Earnings Presentation | Earnings | 15 slides | Nov 10, 2016 |
| Q2 2016 Earnings Presentation | Earnings | 14 slides | Aug 10, 2016 |
| Q1 2016 Earnings Presentation | Earnings | 12 slides | May 10, 2016 |
| Q4 2015 Earnings Presentation | Earnings | 10 slides | Mar 10, 2016 |
| Q3 2015 Earnings Presentation | Earnings | 11 slides | Nov 10, 2015 |
| IPO Roadshow (November 2015) | IPO roadshow | 36 slides | Nov 2, 2015 |
| Investor Presentation (September 2015) | Investor deck | 27 slides | Sep 23, 2015 |
| Q2 2015 Earnings Presentation | Earnings | 8 slides | Aug 11, 2015 |
| Merger or Acquisition (August 2015) | Merger or acquisition | 12 slides | Aug 11, 2015 |
| Q1 2015 Earnings Presentation | Earnings | 12 slides | May 12, 2015 |
| FY2014 Earnings Presentation | Earnings | 13 slides | Mar 12, 2015 |
| IPO Roadshow (October 2013) | IPO roadshow | 37 slides | Oct 17, 2013 |
| Investor Presentation (September 2013) | Investor deck | 36 slides | Sep 20, 2013 |
| IPO Roadshow (August 2013) | IPO roadshow | 36 slides | Aug 5, 2013 |
| IPO Roadshow (July 2013) | IPO roadshow | 36 slides | Jul 29, 2013 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Keith L Brownlie Other companies: Celldex Therapeutics, Inc. (Director · Since at least Jun 15, 2017); Phio Pharmaceuticals Corp. (Director · Mar 1, 2013 – Feb 13, 2019 · Past); Soligenix, Inc. (Director · Jun 21, 2012 – Sep 27, 2018 · Past) | Director · Jul 24, 2013 – May 22, 2014 · Past |
| Geoffrey E Harris Other companies: Vyant Bio Inc (Director · Mar 30, 2021 – Jan 17, 2023 · Past); Emmaus Life Sciences, Inc. (Director · Dec 5, 2017 – Oct 8, 2018 · Past) | Director · Sep 28, 2017 – Jul 23, 2019 · Past |
| John Pappajohn Other companies: American Caresource Holdings Inc (Director · Aug 28, 2015 – Jun 30, 2016 · Past); Emmaus Life Sciences, Inc. (Director · Aug 20, 2015 – May 23, 2019 · Past) | Director · Aug 26, 2015 – Jan 31, 2019 · Past |
| Paul B. Rothman Other companies: Labcorp Holdings Inc. (Director · Since at least Jun 6, 2023); Merck & Company, Inc. (Board Member · Since at least Sep 1, 2015) | Director · Feb 18, 2014 – May 22, 2014 · Past |
| Edmund Cannon | Director · Apr 4, 2013 – Jul 23, 2019 · Past |
| Michael Brian McCartney | Chief Commercial Officer · Jun 12, 2018 – Aug 15, 2018 · Past |
| Steven Hepburn | VP of Biopharma Marketing · May 29, 2015 – May 29, 2015 · Past |
| William Lansing Finger | EVP Precision Medicine · Jan 4, 2019 – Jan 4, 2019 · Past |
Log in to ask 6ix AI your own questions about Cancer Genetics Inc.